These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 2324585)
1. [Antitumor responses after reinfusion of autologous plasma perfused over immobilized protein A: a study in patients at advanced stages of cancer]. Yamamoto T; Okada T; Seshimo T; Abe M; Yano S; Tarumi T; Naitoh A; Tamura K; Nakase A Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):13-24. PubMed ID: 2324585 [TBL] [Abstract][Full Text] [Related]
2. [The repetitive immune cell transfer therapy combining non-myelosuppressive chemotherapy for patients with advanced and refractory cancer]. Toh U; Fujii T; Tayama K; Yanaga H; Yokoyama G; Yamaguchi M; Horiuchi H; Sasatomi T; Takamori S; Shirouzu K; Seki N; Yamana H Gan To Kagaku Ryoho; 2004 Oct; 31(11):1649-51. PubMed ID: 15553672 [TBL] [Abstract][Full Text] [Related]
3. [Conventional chemotherapy combined with the repetitive immune cell transfer for patients with refractory advanced gastric cancer]. Toh U; Fujii T; Mishima M; Imaizumi T; Koga A; Yano S; Shirouzu K; Yahara T; Yamana H Gan To Kagaku Ryoho; 2007 Nov; 34(12):1931-3. PubMed ID: 18219856 [TBL] [Abstract][Full Text] [Related]
4. Histological and ultrastructural changes in breast adenocarcinoma after treatment with plasma perfused over immobilized protein A. Daskal Y; Mattioli CA; Kao-Jen J; Terman DS Cancer Res; 1984 May; 44(5):2225-35. PubMed ID: 6713411 [TBL] [Abstract][Full Text] [Related]
5. Clinical trial of plasma perfusion over immobilized staphylococcal protein A in metastatic breast cancer. Ventura GJ; Buzdar AU; Kau S; Lichtiger B; Hortobagyi GN Cancer Treat Rep; 1987 Apr; 71(4):411-3. PubMed ID: 3548958 [TBL] [Abstract][Full Text] [Related]
6. Staphylococcal Protein A column: correlation of mitogenicity of perfused plasma with clinical response. Bertram JH; Grunberg SM; Shulman I; Apuzzo ML; Boquiren D; Kunkel L; Hengst JC; Nelson J; Waugh WJ; Plotkin D Cancer Res; 1985 Sep; 45(9):4486-94. PubMed ID: 4028030 [TBL] [Abstract][Full Text] [Related]
7. Adsorption of plasma from tumor-bearing hosts over protein A--containing nonviable Staphylococcus aureus Cowan I: possible mechanism of antitumor reactions. Ray PK; McLaughlin D; Allen P; Bandyopadhyay S; Idiculla A; Clarke L; Mark R; Rhoads JE; Bassett JG; Cooper DR J Biol Response Mod; 1984; 3(3):293-302. PubMed ID: 6379112 [TBL] [Abstract][Full Text] [Related]
8. Treatment of advanced malignancy with plasma perfused over staphylococcal protein A. MacKintosh FR; Bennett K; Schiff S; Shields J; Hall SW West J Med; 1983 Jul; 139(1):36-40. PubMed ID: 6624080 [TBL] [Abstract][Full Text] [Related]
9. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol]. Marisavljević D; Bosković D; Radosević N; Elezović I; Tomin D; Gotić M; Antunović P Srp Arh Celok Lek; 1996; 124(11-12):292-6. PubMed ID: 9132962 [TBL] [Abstract][Full Text] [Related]
10. A phase I and pharmacokinetic study of the novel aza-anthracenedione compound BBR 2778 in patients with advanced solid malignancies. Faivre S; Raymond E; Boige V; Gatineau M; Buthaut X; Rixe O; Bernareggi A; Camboni G; Armand JP Clin Cancer Res; 2001 Jan; 7(1):43-50. PubMed ID: 11205916 [TBL] [Abstract][Full Text] [Related]
11. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204 [TBL] [Abstract][Full Text] [Related]
12. Phase I study of liposome-encapsulated c-raf antisense oligodeoxyribonucleotide infusion in combination with radiation therapy in patients with advanced malignancies. Dritschilo A; Huang CH; Rudin CM; Marshall J; Collins B; Dul JL; Zhang C; Kumar D; Gokhale PC; Ahmad A; Ahmad I; Sherman JW; Kasid UN Clin Cancer Res; 2006 Feb; 12(4):1251-9. PubMed ID: 16489081 [TBL] [Abstract][Full Text] [Related]
13. A Phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumors. Rademaker-Lakhai JM; Terret C; Howell SB; Baud CM; De Boer RF; Pluim D; Beijnen JH; Schellens JH; Droz JP Clin Cancer Res; 2004 May; 10(10):3386-95. PubMed ID: 15161693 [TBL] [Abstract][Full Text] [Related]
14. Tumoricidal responses in spontaneous canine neoplasms after extracorporeal perfusion over immobilized protein A. Terman DS Fed Proc; 1981 Jan; 40(1):45-9. PubMed ID: 7450063 [TBL] [Abstract][Full Text] [Related]
15. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues. Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194 [TBL] [Abstract][Full Text] [Related]
16. [Autologous blood transfusion in elective heart surgery: prospective study of 189 consecutive patients]. Mutinelli M; Corallo S; Santoli E; Castelli P; Morandi A; Condemi A; Santoli C G Ital Cardiol; 1989 Feb; 19(2):123-7. PubMed ID: 2788107 [TBL] [Abstract][Full Text] [Related]
17. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related]
18. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
19. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)]. Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148 [TBL] [Abstract][Full Text] [Related]
20. Response to medroxyprogesterone acetate (NSC-26386) as secondary hormone therapy for metastatic breast cancer in postmenopausal women. Klaassen DJ; Rapp EF; Hirte WE Cancer Treat Rep; 1976 Mar; 60(3):251-3. PubMed ID: 1260780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]